Skip to main content
. 2017 Aug 28;10:4225–4238. doi: 10.2147/OTT.S137107

Table S1.

Patient characteristics for PCR-array and qRT-PCR patient cohort

Pateint cohort Case Age (years) Diagnostic Differentiation stage Pathological diagnostic
PCR array 1 58 Endometrioid carcinoma G1 pT1aNxMxL0V0
2 67 Endometrioid carcinoma G2 pT2aNxM1L1V0
3 62 Endometrioid carcinoma G2 pT1cN0MxL1V0
4 54 Endometrioid carcinoma G3 pT2N1M0LoVo
5 59 Endometrioid carcinoma G2 pT1aNxMxLoVo
6 65 Endometrioid carcinoma G3 pT2cN1bMxL1Vo
7 45 Endometrioid carcinoma G3 pT2N1M0LoVo
8 78 Endometrioid carcinoma G2 pT3bNxMxLoVo
9 46 Endometrioid carcinoma G1 pT2aNxMxLoVo
qRT-PCR 1 49 Endometrioid carcinoma G2 pT1aNxMxLoVo
2 62 Endometrioid carcinoma G3 pT1aNxMxLoVo
3 50 Endometrioid carcinoma G3 pT3bNxMxLoVo
4 67 Endometrioid carcinoma G3 pT3cN1MxL1V1
5 51 Endometrioid carcinoma G2 pT2bN0MxLoVo
6 66 Endometrioid carcinoma G3 pT1aNxMxLoVo
7 56 Endometrioid carcinoma G3 pT3cNxMxL1V1
8 42 Endometrioid carcinoma G3 pT2aN0MxLoVo
9 54 Endometrioid carcinoma G2 pT3cN1M1LoVo
10 51 Endometrioid carcinoma G3 pT1aNxMxLoVo
11 64 Endometrioid carcinoma G1 pT1aNxMxLoVo
12 45 Endometrioid carcinoma G1 pT1cNxMxLoVo
13 60 Endometrioid carcinoma G2 pT1aNxMxLoVo
14 66 Endometrioid carcinoma G2 pT2aN1MxLoVo
15 34 Endometrioid carcinoma G2 pT2bN0MxLoVo
16 41 Endometrioid carcinoma G2 pT3cN1MxL1Vo
17 63 Endometrioid carcinoma G1 pT2aN1MxLoVo
18 62 Endometrioid carcinoma G3 pT2bN0MxLoVo
19 44 Endometrioid carcinoma G3 pT1bNxMxLoVo
20 48 Endometrioid carcinoma G1 pT2bN0MxLoVo
21 66 Endometrioid carcinoma G2 pT2bN0MxLoVo
22 64 Endometrioid carcinoma G1 pT1aNxMxLoVo
23 76 Endometrioid carcinoma G2 pT1aNxMxLoVo
24 53 Endometrioid carcinoma G1 pT1aNxMxLoVo
25 68 Endometrioid carcinoma G1 pT1aNxMxLoVo
26 73 Endometrioid carcinoma G3 p3bN0MxLoVo
27 46 Endometrioid carcinoma G1 pT1aNxMxLoVo
28 40 Endometrioid carcinoma G2 pT2cNoMxLoVo

Abbreviation: qRT-PCR, quantitative real-time PCR.